ASMB Assembly Biosciences Inc

Price (delayed)

$35.75

Market cap

$727.89M

P/E Ratio

35.05

Dividend/share

N/A

EPS

$1.02

Enterprise value

$697.96M

?
Relative Growth: Rel. Growth: 25
Relative Strength: Rel. Strength: 85
Relative Valuation: Rel. Valuation: 34
Relative Profitability: Rel. Profitability: 28

Assembly Biosciences is a biotechnology company dedicated to the development of innovative small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. ...

Highlights
ASMB's EPS has surged by 118% year-on-year
ASMB's quick ratio has surged by 111% since the previous quarter

Key stats

What are the main financial stats of ASMB

ASMB stock price

How has the Assembly Biosciences stock price performed over time
Intraday
-2.64%
1 week
2.73%
1 month
40.97%
1 year
49.58%
YTD
5.12%
QTD
30.09%

Financial performance

How have Assembly Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$83.64M
Net income
-$42,000
Gross margin
N/A
Net margin
N/A
Assembly Biosciences's net income has surged by 100% YoY and by 99% QoQ
Assembly Biosciences's operating income has decreased by 9% YoY

Price vs fundamentals

How does ASMB's price correlate with its fundamentals

Growth

What is Assembly Biosciences's growth rate over time

Valuation

What is Assembly Biosciences stock price valuation
P/E
35.05
P/B
1.86
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
10,264.05
EV/Sales
N/A
ASMB's EPS has surged by 118% year-on-year
The equity has soared by 54% from the previous quarter
The price to book (P/B) is 6% higher than the last 4 quarters average of 1.8

Efficiency

How efficient is Assembly Biosciences business performance
The company's return on assets has surged by 100% QoQ and by 100% YoY
The return on equity has surged by 100% since the previous quarter and by 100% year-on-year
The ROIC has soared by 100% from the previous quarter and by 100% YoY

Dividends

What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASMB.

Financial health

How did Assembly Biosciences financials performed over time
ASMB's quick ratio has surged by 111% since the previous quarter
Assembly Biosciences's current ratio has surged by 110% QoQ
The company's debt is 99% lower than its equity
The debt to equity has plunged by 94% YoY
The equity has soared by 54% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.